Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Herceptin (NSC #688097) and Gemcitabine for Metastatic Pancreatic Cancers That Overexpress HER-2/NEU

NCT00003797 is registered in ClinicalTrials.gov with Brown University as lead sponsor.

NCT NCT00003797
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00003797 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Herceptin (NSC #688097) and Gemcitabine for Metastatic Pancreatic Cancers That Overexpress HER-2/NEU
Lead sponsor
Brown University
Phase
Phase 2
Overall status
Unknown status
Start date
March 31, 1999
Completion date
Not reported
Enrollment
41 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic cancer